Rockefeller Capital Management L.P. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q1 2023$249
-34.3%
6,247
-23.8%
0.00%
-50.0%
Q4 2022$379
-99.9%
8,196
+19.9%
0.00%
+100.0%
Q3 2022$282,000
+36.9%
6,836
+96.9%
0.00%0.0%
Q2 2022$206,000
-16.6%
3,472
+1.7%
0.00%0.0%
Q1 2022$247,000
-15.4%
3,414
-2.0%
0.00%0.0%
Q4 2021$292,000
+114.7%
3,482
+129.5%
0.00%0.0%
Q3 2021$136,000
-8.7%
1,517
-3.4%
0.00%0.0%
Q2 2021$149,000
-13.4%
1,571
+3.8%
0.00%0.0%
Q1 2021$172,000
-69.3%
1,513
-62.7%
0.00%
-75.0%
Q4 2020$560,000
+216.4%
4,054
+86.9%
0.00%
+100.0%
Q3 2020$177,000
+7.3%
2,169
+2.6%
0.00%0.0%
Q2 2020$165,000
+75.5%
2,1140.0%0.00%
+100.0%
Q1 2020$94,000
-14.5%
2,114
-18.0%
0.00%0.0%
Q4 2019$110,000
-6.0%
2,577
-5.8%
0.00%
-50.0%
Q3 2019$117,000
-34.3%
2,737
-2.4%
0.00%0.0%
Q2 2019$178,000
+14.1%
2,803
+25.1%
0.00%0.0%
Q1 2019$156,000
+69.6%
2,241
+5.9%
0.00%0.0%
Q4 2018$92,000
-43.2%
2,1160.0%0.00%0.0%
Q3 2018$162,000
-0.6%
2,1160.0%0.00%
-33.3%
Q2 2018$163,000
+50.9%
2,1160.0%0.00%
+50.0%
Q1 2018$108,0002,1160.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders